Empaveli 1080 MG

Ended Awarded

Contract number
36C24524N0804
Awardee
Awarding agency
Obligated
$25,831

Award facts

Contract value 100% obligated
$25,831.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Pittsburgh, PA 15275, USA

Award details come from SAM.gov/FPDS.

About this award

This is a $25,831.04 firm fixed price delivery order awarded to APL Sales I LLC, a subsidiary of Apellis Pharmaceuticals, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5. The order is for the delivery of EMPAVELI, a drug used to treat paroxysmal nocturnal hemoglobinuria, to VA facilities in Pittsburgh, Pennsylvania. The delivery order is issued under APL Sales I LLC's Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, with a ceiling value of $225,000 and a period of performance through December 2026. APL Sales I LLC also holds a $2 million single-award Blanket Purchase Agreement with the VA National Acquisition Center for the supply of Empagliflozin, a diabetes treatment drug. These contracts support the VA's mission to provide healthcare services to veterans by ensuring a steady supply of critical medications. No set-aside designation is mentioned for this specific delivery order.

Quick answers

Who was awarded contract 36C24524N0804?

36C24524N0804 was awarded to APL Sales I LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 7, 2024.

How much is contract 36C24524N0804 worth?

The government has obligated $25,831 on 36C24524N0804.

Is contract 36C24524N0804 an order under another contract?

Yes. 36C24524N0804 is a delivery order under 36F79722D0039, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24524N0804 competed?

The extent of competition for 36C24524N0804 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award